© 2024 SEISMIC TX. ALL RIGHTS RESERVED.
WATERTOWN, Mass., June 25, 2024 — Seismic Therapeutic, Inc., the machine learning immunology company, today announced the appointment of Brendan St. Amant as General Counsel and a member of the company’s leadership team. Mr. St. Amant brings more than 16 years of combined law firm and in-house experience across a range of areas, including corporate governance, securities and disclosure matters, regulatory and corporate compliance, business development and financing transactions, general business law, and managing legal and intellectual property functions at public and private biotechnology companies.
“We are delighted to welcome Brendan to the Seismic leadership team. He joins us at a time when we are rapidly evolving into a clinical-stage company, and his business skills and legal expertise will be highly valuable as we make progress toward important clinical and business milestones,” said Jo Viney, PhD, Co-Founder, President and CEO of Seismic. “Brendan has an outstanding track record as a business leader and legal expert, and his background at biotechnology companies is ideally suited to further strengthen our business excellence and help Seismic capture the tremendous opportunities ahead of us.”
“I am thrilled to join Seismic’s exceptional team and culture at a time when the company has such positive momentum in advancing its pipeline and business,” said Brendan St. Amant. “I look forward to collaborating with the leadership team to help Seismic achieve its goal of creating next generation immunology drugs for patients.”
Prior to joining Seismic, Brendan was General Counsel and Corporate Secretary for Synlogic, Inc., a publicly traded biotech company with a phase 3 clinical drug program. Previously, he was Vice President, Legal, and member of the leadership team at Ohana Biosciences and was senior counsel at Vertex Pharmaceuticals. Brendan was a partner at the law firm of Donnelly, Conroy & Gelhaar, LLP, in Boston where he focused on complex commercial controversies and government enforcement. Earlier in his legal career, Brendan served as a clerk for the Hon. Alvin W. Thompson, Chief, U.S. District Court for the District of Connecticut and was an associate at the law firm of Goodwin Procter. Brendan has served on several practice-related bar committees and on the executive committee of the Board of Trustees of the Massachusetts Continuing Legal Education corporation. He received his BA from Cornell University, JD from Harvard Law School, and his MPP from the Harvard Kennedy School.
About Seismic Therapeutic
Seismic Therapeutic™ is a biotechnology company making a major shift in how immunology therapies are discovered and developed, enabled by machine learning. The company has a growing preclinical stage best-in-class and first-in-class biologics pipeline, derived from its integrated IMPACT platform, to control dysregulated adaptive immunity and address multiple autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub. For more information, please visit www.seismictx.com and follow us on LinkedIn and on X @Seismic_Tx.
Media Contact
Kathryn Morris, The Yates Network
914-204-6412
kathryn@theyatesnetwork.com
Investor Contact
Emiley Demick, Precision AQ (formerly known as Stern IR)
212-362-1200
emiley.demick@precisionaq.com
This links to an external website.